(PharmaNewsWire.Com, May 02, 2020 ) The report "Healthcare EDI Market by Component (Solution, Service), Delivery Mode (Web & Cloud, Mobile) Transaction Type (Claims Management, Remittance, Payments, Healthcare Supply Chain), End User (Healthcare Provider, Payer, Pharmacies) - Global Forecast to 2022", The healthcare EDI market is expected to reach USD 3.77 Billion by 2022 from an estimated USD 2.56 Billion in 2017, at a CAGR of 8.1%. The growth of the market is mainly driven by the rising need to curtail healthcare costs, mandatory regulations for transaction processes, and government support for HCIT.
“By component, the services segment accounted for the largest share of the market in 2016.”
On the basis of component, the services segment accounted for the largest share of the global healthcare EDI market. This is primarily attributed to the increasing complexity and scale of EDI solutions, as they require extensive training programs, and rise in outsourcing activities. The services segment is also expected to grow at the highest CAGR during the forecast period.
“By delivery mode, the web & cloud-based EDI segment held the largest market share in 2016.”
Based on delivery mode, the web & cloud-based EDI segment accounted for the largest share of this market. The low cost of web and cloud-based EDI, non-requirement of software installations, compatibility with mobile devices, and high scalability are the major factors driving the use of web & cloud-based EDI, which has boosted the demand for effective EDI implementation.
“North America dominated the market in 2016.”
North America accounted for the largest share of the healthcare EDI market in 2016, followed by Europe and Asia-Pacific. Factors such as the high adoption rate of HCIT technologies, regulatory requirements regarding patient safety, the presence of a large number of HCIT companies in the region, and growing demand for innovative IT solutions to streamline workflows are contributing to the large share of North America. The rising adoption of EDI services by hospitals in supply chain management and government efforts to improve healthcare coverage & streamline healthcare delivery & reimbursement processes are majorly contributing to the growth of the European healthcare EDI market, which holds the second-largest market share.
The prominent players in the global healthcare EDI market are McKesson Corporation (U.S.), GE Healthcare (U.S.), Allscripts Healthcare Solutions Inc. (U.S.), Cognizant Technology Corporation (U.S.), SSI Group, LLC (U.S.), Cerner Corporation (U.S.), Comarch SA (Poland), Axway Software SA (France), Optum Inc. (U.S.), Dell Technologies Inc. (U.S.), Quality Systems Inc. (U.S.), and Synnex Corporation (U.S.).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
